BSECompany Update7 Aug 2026 · 7 Aug 2026, 06:56 pm
Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Tatva Chintan Pharma Chem Ltd · 543321
✦ AI SummaryMgmt Change
Tatva Chintan Pharma Chem Ltd has announced a schedule of analyst/investor meetings under SEBI regulations, with two virtual meetings on August 12, 2026, with Ambit Global Private and TA Associate.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
581ae0b3-f4f3-4de6-afb3-02acb2741673.pdf
View document text
Date:07August 2026 Ref.No.:TCPCL/SEC/2026-27/00034
TheGeneralManager, TheManager,
Corporaterelationshipdepartment, Listingdepartment,
BSELimited NationalStockExchangeofIndiaLimited
PhirozeJeejeebhoyTowers, ExchangePlaza,C-1,Block-G,
DalalStreet,Fort, Bandra-KurlaComplex,Bandra(E),
Mumbai-400001 Mumbai-400051
ScripCode:543321 ScripSymbol:TATVA
Subject:IntimationofScheduleofAnalyst(s)/Financial Institution(s)/Investor(s) Meeting
DearSir/Madam,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015, as amended, we hereby submit schedule of Analyst(s)/Financial Institution(s)/Investor(s) meeting
thattheCompanywouldbeparticipating:
Sr. Date Analyst(s)/Financial Type Mode
No. Institution(s)/Investor(s)
1. 12August 2026 AmbitGlobalPrivate OnetoOneMeeting VirtualMeeting
Client
2. 12August 2026 TAAssociate OnetoOneMeeting VirtualMeeting
Pleasenotethattheaboveissubjecttochange,ifany.
The Company will be referring to publicly available information for discussions during interaction in
themeeting.
Noconfidential/unpublishedpricesensitiveinformation(UPSI)willbesharedduringthemeeting.
The above information shall be made available on the website of the Company at
www.tatvachintan.com.
Kindlytakeaboveintimationonyourrecordandoblige.
Thankingyou,
Yoursfaithfully,
ForTatvaChintanPharmaChemLimited
IshwarNayi
CompanySecretaryandComplianceOfficer
M.No.:A37444